These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

53 related items for PubMed ID: 4310618

  • 1. Non-identity between pulmonary bradykininase and converting-enzyme activity.
    Scholz HW, Biron P.
    Rev Can Biol; 1969 Sep; 28(3):197-200. PubMed ID: 4310618
    [No Abstract] [Full Text] [Related]

  • 2. Converting enzyme and bradykininase in the lung.
    Alabaster VA, Bakhle YS.
    Circ Res; 1972 Sep; 31(9):Suppl 2:72-84. PubMed ID: 4341482
    [No Abstract] [Full Text] [Related]

  • 3. The bradykininase activities of extracts of dog lung.
    Alabaster VA, Bakhle YS.
    Br J Pharmacol; 1973 Apr; 47(4):799-807. PubMed ID: 4723801
    [Abstract] [Full Text] [Related]

  • 4. In vivo pulmonary metabolism of bradykinin, angiotensin I and 5-hydroxtryptamine in the rat.
    Freer RJ, Stewart JM.
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):97-109. PubMed ID: 172037
    [Abstract] [Full Text] [Related]

  • 5. The inactivation of bradykinin in the pulmonary circulation of isolated lungs.
    Alabaster VA, Bakhle YS.
    Br J Pharmacol; 1972 Jun; 45(2):299-310. PubMed ID: 4625922
    [Abstract] [Full Text] [Related]

  • 6. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA, Marchini F, Morazzoni G, Vegh A, Papp JG, Parratt JR.
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary angiotensin-converting enzyme. Interspecies homology and inhibition by heterologous antibody in vivo.
    Conroy JM, Hoffman H, Kirk ES, Hirzel HO, Sonnenblick EH, Soffer RL.
    J Biol Chem; 1976 Aug 25; 251(16):4828-32. PubMed ID: 182680
    [Abstract] [Full Text] [Related]

  • 8. Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
    Aubert JF, Waeber B, Nussberger J, Vavrek R, Stewart JM, Brunner HR.
    Agents Actions Suppl; 1987 Aug 25; 22():349-54. PubMed ID: 3324717
    [Abstract] [Full Text] [Related]

  • 9. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.
    Campbell DJ, Alexiou T, Xiao HD, Fuchs S, McKinley MJ, Corvol P, Bernstein KE.
    Hypertension; 2004 Apr 25; 43(4):854-9. PubMed ID: 14769811
    [Abstract] [Full Text] [Related]

  • 10. [Relationship between the kininase and angiotensin-converting lung functions in rabbits with cerebroischemic and renovascular hypertension].
    Karpitskiĭ VV, Gomazkov OA.
    Biull Eksp Biol Med; 1982 Jan 25; 93(1):24-6. PubMed ID: 6279206
    [No Abstract] [Full Text] [Related]

  • 11. Gynura procumbens causes vasodilation by inhibiting angiotensin II and enhancing bradykinin actions.
    Poh TF, Ng HK, Hoe SZ, Lam SK.
    J Cardiovasc Pharmacol; 2013 May 25; 61(5):378-84. PubMed ID: 23328388
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin I [Phe8-His9] hydrolase and bradykininase from human lung.
    Overturf M, Wyatt S, Boaz D, Fitz A.
    Life Sci; 1975 Jun 01; 16(11):1669-81. PubMed ID: 167251
    [No Abstract] [Full Text] [Related]

  • 13. Some properties of angiotensin converting enzyme in the lung in vivo.
    Ng KK, Vane JR.
    Nature; 1970 Mar 21; 225(5238):1142-4. PubMed ID: 4313869
    [No Abstract] [Full Text] [Related]

  • 14. Effect of a fibrin-derived vasoactive peptide on pulmonary angiotensin converting enzyme activity and on pressure responses to bradykinin.
    Moalli R, Saldeen K, Saldeen T.
    J Pharmacol Exp Ther; 1987 Dec 21; 243(3):897-900. PubMed ID: 3694536
    [Abstract] [Full Text] [Related]

  • 15. Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung.
    Bakhle YS.
    Nature; 1968 Nov 30; 220(5170):919-21. PubMed ID: 4301850
    [No Abstract] [Full Text] [Related]

  • 16. Angiotensin antogonists as pharmacological tools.
    Needleman P, Douglas JR, Jakschik BA, Blumberg AL, Isakson PC, Marshall GR.
    Fed Proc; 1976 Nov 30; 35(13):2488-93. PubMed ID: 185093
    [Abstract] [Full Text] [Related]

  • 17. The effects of the intraventricular administration of angiotensin II, bradykinin and eledoisin on the arterial blood pressure, respiratory movements and electrocardiogram.
    Cuparencu B, Ticşa I, Safta L, Csutak V, Mocan R.
    Rev Roum Physiol; 1969 Nov 30; 6(3):213-20. PubMed ID: 4323315
    [No Abstract] [Full Text] [Related]

  • 18. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
    Schwieler JH, Kahan T, Nussberger J, Hjemdahl P.
    Acta Physiol Scand; 1994 Sep 30; 152(1):83-91. PubMed ID: 7810335
    [Abstract] [Full Text] [Related]

  • 19. On the potentiation of kinins by sulfhydrylic compounds.
    Auerswald W, Doleschel W.
    Arch Int Pharmacodyn Ther; 1967 Jul 30; 168(1):188-98. PubMed ID: 4292761
    [No Abstract] [Full Text] [Related]

  • 20. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W, Fournié-Zaluski MC, Pham I, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1995 Jan 30; 272(1):343-51. PubMed ID: 7815350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.